SMTI — Sanara Medtech Cashflow Statement
0.000.00%
- $260.05m
- $266.64m
- $64.99m
- 65
- 28
- 57
- 48
Annual cashflow statement for Sanara Medtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.84 | -4.45 | -7.99 | -8.09 | -4.44 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.188 | 1.3 | 3.76 | 5.49 | 0.7 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.361 | -1.18 | -1.18 | 0.518 | -3.18 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.17 | -4.03 | -4.81 | -5.55 | -3.25 |
Capital Expenditures | -1.71 | -1.64 | -0.75 | -0.747 | -0.265 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.508 | -1.1 | -4.53 | -2.76 | -9.94 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.2 | -2.74 | -5.28 | -3.51 | -10.2 |
Financing Cash Flow Items | 9.8 | 0 | -0.643 | -0.627 | -0.047 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 9.8 | 0.622 | 28.3 | -0.627 | 9.64 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.44 | -6.16 | 18.2 | -9.69 | -3.81 |